Answers are grounded in this paper and cite their sources.
Real-world evidence shows rising healthcare costs in chronic kidney disease, indicating a need for better management strategies.
In real-world, CKD may be associated with high healthcare resource utilization and costs that increase as renal function worsens or albuminuria levels increase. Reducing economic burden through primordial and primary prevention policies, and comprehensive management with kidney protective drugs should be a priority.
No takes yet. Share an insight, caveat, or question.
Santamaria et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: